一种调整随机临床试验中挽救治疗的新估计目标
针对随机临床试验中挽救用药干扰意向性治疗分析的问题,提出一种新估计目标:假设活动组患者当且仅当在对照组会被换用挽救药时才换药,从而分离治疗效应与挽救药效应。提出逆概率加权估计法并用于Janssen的2型糖尿病试验,蒙特卡洛模拟显示中等样本量下估计无偏。
要点
- 新估计目标可分离随机治疗效应与挽救用药效应。
- 逆概率加权法适用于预设单一时间点启动挽救治疗的情形。
- 需敏感性分析应对不可检验假设,模拟显示中等样本量无偏。
核心结论
- 新估计目标定义的活动组换药规则为当且仅当对照组会换药时才换药,可分离治疗与挽救用药效应。
- 所提逆概率加权估计法在中等样本量模拟中表现无偏。
研究设计与样本
- 方法学论文,提出新估计目标与逆概率加权估计法,并用于Janssen Pharmaceuticals的2型糖尿病临床试验。
- 采用蒙特卡洛模拟评估估计量在中等样本量下的表现。
主要发现
- 蒙特卡洛模拟确认所提估计量在中等样本量下无偏。
- 该方法已应用于2型糖尿病试验,该试验中患者可因伦理原因换用挽救药物。
临床怎么用
- 在挽救用药常见且干扰意向性治疗解释的试验中,可用该估计目标与方法分离治疗效应。
- 应用时需针对不可检验假设开展敏感性分析。
局限性
- 估计量依赖特定不可检验假设,需敏感性分析。
- 方法设定为挽救用药决策在单一预设时间点做出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The interpretation of randomized clinical trial results is often complicated by intercurrent events. For instance, rescue medication is sometimes given to patients in response to worsening of their disease, either in addition to the randomized treatment or in its place. The use of such medication complicates the interpretation of the intention-to-treat analysis. In view of this, we propose a novel estimand defined as the intention-to-treat effect that would have been observed, had patients on the active arm been switched to rescue medication if and only if they would have been switched when randomized to control. This enables us to disentangle the treatment effect from the effect of rescue medication on a patient's outcome, while tempering the strong extrapolations that are typically needed when inferring what the intention-to-treat effect would have been in the absence of rescue medication. We propose a novel inverse probability weighting method for estimating this effect in settings where the decision to initiate rescue medication is made at one prespecified time point. This estimator relies on specific untestable assumptions, in view of which we propose a sensitivity analysis. We use the method for the analysis of a clinical trial conducted by Janssen Pharmaceuticals, in which patients with type 2 diabetes mellitus can switch to rescue medication for ethical reasons. Monte Carlo simulations confirm that the proposed estimator is unbiased in moderate sample sizes.
引用
- Michiels H, Sotto C, Vandebosch A, et al. A novel estimand to adjust for rescue treatment in randomized clinical trials. Stat Med. 2021. PMID: 33567475. doi:10.1002/sim.8901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。